


Finkelstein Thompson LLP Announces Investigation of Argon ST, Inc.
WASHINGTON--([ BUSINESS WIRE ])--Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Argon ST, Inc. (aArgona or the aCompanya) (Nasdaq: STST) arising from the Companya™s announcement of its intent to be acquired by The Boeing Co. (aBoeinga). Under the terms of the agreement, Argon shareholders will receive $34.50 in cash for every share of Argon stock they own in a transaction valued at approximately $775 million.
The investigation is focused on the potential unfairness of the consideration to Argona™s shareholders and the process by which Argona™s Board of Directors considered and approved the transaction. For example, it is expected that Argona™s Chairman and CEO and his amanagement teama will continue to run the Company as a stand-alone subsidiary of Boeing following the completion of the transaction.
If you are interested in discussing your rights as an Argon shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at [ contact@finkelsteinthompson.com ].
Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.
To learn more about Finkelstein Thompson LLP, please visit our web site at [ www.finkelsteinthompson.com ]. Attorney advertising. Prior results do not guarantee similar outcomes.